Scholarlink

Background <p>Exome sequencing (ES) and genome sequencing (GS) are increasingly used as standard genetic tests to identify diagnostic variants in rare disease cases. However, prioritizing these variants to reduce the time and burden of manual interpretation by clinical teams remains a significant challenge. The Exomiser/Genomiser software suite is the most widely adopted open-source software for prioritizing coding and noncoding variants. Despite its ubiquitous use, limited data-driven guidelines currently exist to optimize its performance for diagnostic variant prioritization. Based on detailed analyses of Undiagnosed Diseases Network (UDN) probands, this study presents optimized parameters and practical recommendations for deploying the Exomiser and Genomiser tools. We also highlight scenarios where diagnostic variants may be missed and propose alternative workflows to improve diagnostic success in such complex cases.</p> Methods <p>We analyzed 386 diagnosed probands from the UDN, including cases with coding and noncoding diagnostic variants. We systematically evaluated how tool performance was affected by key parameters, including gene:phenotype association data, variant pathogenicity predictors, phenotype term quality and quantity, and the inclusion and accuracy of family variant data.</p> Results <p>Parameter optimization significantly improved Exomiser’s performance over default parameters. For GS data, the percentage of coding diagnostic variants ranked within the top 10 candidates increased from 49.7% to 85.5%, and for ES, from 67.3% to 88.2%. For noncoding variants prioritized with Genomiser, the top 10 rankings improved from 15.0% to 40.0%. We also explored refinement strategies for Exomiser outputs, including using <i>p</i>-value thresholds and flagging genes that are frequently ranked in the top 30 candidates but rarely associated with diagnoses.</p> Conclusion <p>This study provides an evidence-based framework for variant prioritization in ES and GS data using Exomiser and Genomiser. These recommendations have been implemented in the Mosaic platform to support the ongoing analysis of undiagnosed UDN participants and provide efficient, scalable reanalysis to improve diagnostic yield. Our work also highlights the importance of tracking solved cases and diagnostic variants that can be used to benchmark bioinformatics tools. Exomiser and Genomiser are available at <a href="https://github.com/exomiser/Exomiser/">https://github.com/exomiser/Exomiser/</a>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

An optimized variant prioritization process for rare disease diagnostics: recommendations for Exomiser and Genomiser

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月21日

查看全文
  • Isabelle B. Cooperstein,
  • Shruti Marwaha,
  • Alistair Ward,
  • Shilpa N. Kobren,
  • Jennefer N. Carter,
  • Aaron Quinlan,
  • Abdul Elkadri,
  • Adeline Vanderver,
  • Adriana Rebelo,
  • Alan H Beggs,
  • Albert R La Spada,
  • Alden Huang,
  • Alex Paul,
  • Alexander Miller,
  • Alistair Ward,
  • Allen Bale,
  • Allyn McConkie-Rosell,
  • Alyson Krokosky,
  • Alyssa A Tran,
  • Andrea Gropman,
  • Andres Vargas,
  • Andrew B Crouse,
  • Andrew Stergachis,
  • Anna Hurst,
  • Anna Raper,
  • Anne Slavotinek,
  • Arian Nouraee,
  • Arjun Tarakad,
  • Ashley Andrews,
  • Ashley McMinn,
  • Ashok Balasubramanyam,
  • Ayuko Iverson,
  • Barbara N Pusey Swerdzewski,
  • Beatriz Anguiano,
  • Ben Afzali,
  • Ben Solomon,
  • Beth A Martin,
  • Bianca E Russell,
  • Brandon M Wilk,
  • Breanna Mitchell,
  • Brendan C Lanpher,
  • Brendan H Lee,
  • Brent L Fogel,
  • Brett Bordini,
  • Brett H Graham,
  • Brianna Tucker,
  • Bruce Gelb,
  • Bruce Korf,
  • Calum A MacRae,
  • Camilo Toro,
  • Cara Skraban,
  • Carlos A Bacino,
  • Carlos A Pardo-Villamizar,
  • Carlos Prada,
  • Carol Oladele,
  • Caroline Hendry,
  • Carson A Smith,
  • Cathy Shyr,
  • Cecilia Esteves,
  • Changrui Xiao,
  • Charlotte Cunningham-Rundles,
  • Chloe M Reuter,
  • Christine M Eng,
  • Christopher Mayhew,
  • Chun-Hung Chan,
  • Colleen E Wahl,
  • Corrine K Welt,
  • Cynthia J Tifft,
  • Dana Kiley,
  • Dana Sayer,
  • Daniel J Rader,
  • Daniel Wegner,
  • Danny E Miller,
  • Daryl A Scott,
  • Dave Viskochil,
  • David A Sweetser,
  • David R Adams,
  • Deborah Barbouth,
  • Deepak A Rao,
  • Devin Oglesbee,
  • Devon Bonner,
  • Donald Basel,
  • Donna Novacic,
  • Francisco Bustos velasq,
  • Dustin Baldridge,
  • Edward Behrens,
  • Edwin K Silverman,
  • Elaine Seto,
  • Elijah Kravets,
  • Elisabeth Rosenthal,
  • Elizabeth A Worthey,
  • Elizabeth A Burke,
  • Elizabeth Blue,
  • Elizabeth C Chao,
  • Elizabeth L Fieg,
  • Elizabeth Wohler,
  • Ellen F Macnamara,
  • Elsa Balton,
  • Emily Glanton,
  • Emily Shelkowitz,
  • Emily Wang,
  • Eneida Mendonca,
  • Eric Allenspach,
  • Eric Gamazon,
  • Eric Gayle,
  • Eric Klee,
  • Eric Vilain,
  • Erica Davis,
  • Erin Conboy,
  • Erin E Baldwin,
  • Erin McRoy,
  • Esteban C Dell’Angelica,
  • Euan A Ashley,
  • F Sessions Cole,
  • Filippo Pinto E Vairo,
  • Frances High,
  • Francesco Vetrini,
  • Francis Rossignol,
  • Fuki M Hisama,
  • Gabor Marth,
  • Gail P Jarvik,
  • Gary D Clark,
  • George Carvalho,
  • Gerard T Berry,
  • Ghayda Mirzaa,
  • Giorgio Sirugo,
  • Gonench Kilich,
  • Guney Bademci,
  • Hector Rodrigo Mendez,
  • Heidi Wood,
  • Herman Taylor,
  • Holly K Tabor,
  • Hongzheng Dai,
  • Hsiao-Tuan Chao,
  • Hua Xu,
  • Hugo J Bellen,
  • Hui Zhang,
  • Ian Glass,
  • Ian R Lanza,
  • Ingrid A Holm,
  • Isaac S Kohane,
  • Isum Ward,
  • Ivan Chinn,
  • J Carl Pallais,
  • Jacinda B Sampson,
  • James P Orengo,
  • James Verbsky,
  • Jared Sninsky,
  • Jason Hom,
  • Jason Schend,
  • Jennefer N Kohler,
  • Jennifer Morgan,
  • Jennifer Schymick,
  • Jennifer Tousseau,
  • Jennifer Wambach,
  • Jessica Douglas,
  • Jiayu Fu,
  • Jill A Rosenfeld,
  • Jimann Shin,
  • Joan M Stoler,
  • Joanna Jen,
  • Joanna M Gonzalez,
  • John A Phillips III,
  • John Carey,
  • John E Gorzynski,
  • John J Mulvihill,
  • Joie Davis,
  • Jonathan A Bernstein,
  • Jordan Whitlock,
  • Jose Abdenur,
  • Joseph Loscalzo,
  • Joy D Cogan,
  • Julian A Martínez-Agosto,
  • Julie Hoover-Fong,
  • Julie McCarrier,
  • Justin Alvey,
  • Kahlen Darr,
  • Kai Lee Yap,
  • Kaitlin Callaway,
  • Kathleen A Leppig,
  • Kathleen Page,
  • Kathleen Sullivan,
  • Kathy Sisco,
  • Katrina Dipple,
  • Kayla M Treat,
  • Kelly Hassey,
  • Kelly Regan-Fendt,
  • Kelly Schoch,
  • Kevin S Smith,
  • Khurram Liaqat,
  • Kim Worley,
  • Kimberly Ezell,
  • Kimberly LeBlanc,
  • Kirsten Blanco,
  • Kumarie Latchman,
  • Lakshitha Perera,
  • Lance H Rodan,
  • Laura Keehan,
  • Laurel A Cobban,
  • Lauren Blieden,
  • Lauren C Briere,
  • Lauren Jeffries,
  • Laurens Wiel,
  • Layal F Abi Farraj,
  • Leoyklang Petcharet,
  • LéShon Peart,
  • Lili Mantcheva,
  • Lilianna Solnica-Krezel,
  • Lindsay C Burrage,
  • Lindsay Mulvihill,
  • Lisa Bastarache,
  • Lisa Schimmenti,
  • Lisa T Emrick,
  • Lorenzo Botto,
  • Lorraine Potocki,
  • Louise Bier,
  • Lynette Rives,
  • Lynne A Wolfe,
  • Mafalda Barbosa,
  • Maija-Rikka Steenari,
  • Manish J Butte,
  • Manisha Balwani,
  • Margaret Delgado,
  • María José Ortuño Romero,
  • María Paula Silva,
  • Maria T Acosta,
  • Marie Morimoto,
  • Mariko Nakano-Okuno,
  • Mariya Shadrina,
  • Mark Gerstein,
  • Mark Wener,
  • Marla Sabaii,
  • Martha Horike-Pyne,
  • Martin G Martin,
  • Martin Rodriguez,
  • Mary Koziura,
  • Matt Velinder,
  • Matthew Coggins,
  • Matthew Might,
  • Matthew Robinson,
  • Matthew T Wheeler,
  • MayChristine V Malicdan,
  • Megan Bell,
  • Meghan C Halley,
  • Melissa Walker,
  • Mia Levanto,
  • Michael Bamshad,
  • Michael F Wangler,
  • Michael Muriello,
  • Michael T Zimmermann,
  • Michele Spencer-Manzon,
  • Miranda Leitheiser,
  • Mohamad Mikati,
  • Mohamad Saifeddine,
  • Monika Weisz Hubshman,
  • Monkol Lek,
  • Monte Westerfield,
  • Mustafa Tekin,
  • Nada Derar,
  • Naghmeh Dorrani,
  • Nara Sobreira,
  • Neil H Parker,
  • Neil Hanchard,
  • Nicholas Borja,
  • Nicola Longo,
  • Nicole M Walley,
  • Nitsuh K Dargie,
  • Odelya Kaufman,
  • Oguz Kanca,
  • Orpa Jean-Marie,
  • Page C Goddard,
  • Paolo Moretti,
  • Patricia A Ward,
  • Patricia Dickson,
  • Patrick McMullen,
  • Paul Auwaerter,
  • Paul Berger,
  • Paul G Fisher,
  • Pengfei Liu,
  • Peter Byers,
  • Philip Dane Witmer,
  • Pinar Bayrak-Toydemir,
  • Pongtawat Lertwilaiwittaya,
  • Precilla D’Souza,
  • Queenie Tan,
  • Rachel A Ungar,
  • Rachel Evard,
  • Rachel Li,
  • Rakale C Quarells,
  • Ramakrishnan Rajagopalan,
  • Raquel L Alvarez,
  • Reaford Blackburn,
  • Rebecca C Spillmann,
  • Rebecca Ganetzky,
  • Rebecca Overbury,
  • Rebekah Barrick,
  • Richard A Lewis,
  • Richard Chang,
  • Richard L Maas,
  • Rizwan Hamid,
  • Rong Mao,
  • Ronit Marom,
  • Rosario I Corona,
  • Runjun Kumar,
  • Russell Butterfield,
  • Sanaz Attaripour,
  • Sandesh Nagamani,
  • Sara Emami,
  • Saskia Shuman,
  • Seema R Lalani,
  • Seth Perlman,
  • Shamika Ketkar,
  • Shamil R Sunyaev,
  • Shilpa N Kobren,
  • Shinya Yamamoto,
  • Shrikant Mane,
  • Shruti Marwaha,
  • Sirisak Chanprasert,
  • Stanley F Nelson,
  • Stephan Zuchner,
  • Stephanie Bivona,
  • Stephanie M Ware,
  • Stephen B Montgomery,
  • Stephen C Pak,
  • Steven Boyden,
  • Suha Bachir,
  • Surendra Dasari,
  • Susan Korrick,
  • Susan Shin,
  • Suzanne Sandmeyer,
  • Tahseen Mozaffar,
  • Tammi Skelton,
  • Tanner D Jensen,
  • Tarun KK Mamidi,
  • Taylor Beagle,
  • Taylor Maurer,
  • Teneasha Washington,
  • Teodoro Jerves Serrano,
  • Terra R Coakley,
  • Thomas Cassini,
  • Thomas J Nicholas,
  • Timothy Schedl,
  • Tiphanie P Vogel,
  • Vaidehi Jobanputra,
  • Valerie V Maduro,
  • Vandana Shashi,
  • Vasilis Vasiliou,
  • Virginia Sybert,
  • Vishnu Cuddapah,
  • Wendy Introne,
  • Wendy Raskind,
  • Willa Thorson,
  • William A Gahl,
  • William E Byrd,
  • William J Craigen,
  • Winston Halstead,
  • Winston Timp,
  • Yan Huang,
  • Yigit Karasozen,
  • Yong-Hui Jiang,
  • Yuka Manabe,
  • Zackary Dov Berger,
  • Ziyuan Guo,
  • Matthew T. Wheeler,
  • Gabor T. Marth

摘要

Background

Exome sequencing (ES) and genome sequencing (GS) are increasingly used as standard genetic tests to identify diagnostic variants in rare disease cases. However, prioritizing these variants to reduce the time and burden of manual interpretation by clinical teams remains a significant challenge. The Exomiser/Genomiser software suite is the most widely adopted open-source software for prioritizing coding and noncoding variants. Despite its ubiquitous use, limited data-driven guidelines currently exist to optimize its performance for diagnostic variant prioritization. Based on detailed analyses of Undiagnosed Diseases Network (UDN) probands, this study presents optimized parameters and practical recommendations for deploying the Exomiser and Genomiser tools. We also highlight scenarios where diagnostic variants may be missed and propose alternative workflows to improve diagnostic success in such complex cases.

Methods

We analyzed 386 diagnosed probands from the UDN, including cases with coding and noncoding diagnostic variants. We systematically evaluated how tool performance was affected by key parameters, including gene:phenotype association data, variant pathogenicity predictors, phenotype term quality and quantity, and the inclusion and accuracy of family variant data.

Results

Parameter optimization significantly improved Exomiser’s performance over default parameters. For GS data, the percentage of coding diagnostic variants ranked within the top 10 candidates increased from 49.7% to 85.5%, and for ES, from 67.3% to 88.2%. For noncoding variants prioritized with Genomiser, the top 10 rankings improved from 15.0% to 40.0%. We also explored refinement strategies for Exomiser outputs, including using p-value thresholds and flagging genes that are frequently ranked in the top 30 candidates but rarely associated with diagnoses.

Conclusion

This study provides an evidence-based framework for variant prioritization in ES and GS data using Exomiser and Genomiser. These recommendations have been implemented in the Mosaic platform to support the ongoing analysis of undiagnosed UDN participants and provide efficient, scalable reanalysis to improve diagnostic yield. Our work also highlights the importance of tracking solved cases and diagnostic variants that can be used to benchmark bioinformatics tools. Exomiser and Genomiser are available at https://github.com/exomiser/Exomiser/.